Eklira Genuair

Eklira Genuair is an inhalation medication containing aclidinium bromide, used for managing chronic obstructive pulmonary disease (COPD). This bronchodilator helps improve breathing by relaxing airway muscles.

Eklira Genuair is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by opening the airways, making it easier to breathe. People often ask, 'What is Eklira Genuair used for?' It is designed for long-term management rather than immediate relief.

Common effects of Eklira Genuair may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness. These effects vary and are not experienced by everyone.

Eklira Genuair should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Keep the medication out of reach of children and store it properly.

Eklira Genuair may interact with other medications, including anticholinergics and beta-blockers. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.